CLOFIBRATE

Clofibrate lowers triglycerides by enhancing lipid metabolism. Side effects include GI upset and gallstone risk.

SKU: d1d30f1adacc Category: Tag:

Product Description


Mechanism of Action

Clofibrate is a fibrate‑class lipid regulator that activates PPAR‑α, increasing fatty‑acid oxidation and reducing serum triglycerides. It enhances lipoprotein‑lipase activity and modulates hepatic lipid metabolism.

Benefits and Advantages

Used in lipid‑metabolism research, fibrate SAR studies, triglyceride‑lowering modelling, hepatic‑gene expression assays and PPAR‑targeted drug development.

Side Effects and Risks

Risks include gallstone formation, hepatotoxicity, myopathy and GI upset. Handle with lipid‑active agent precautions.

Datasheet


Molecular Formula

C12H15ClO3

Molecular Weight

242.70 g/mol

CAS Number

637-07-0

Storage Condition

Clofibrate liquid-filled capsules should be stored in well-closed, light-resistant containers, @ a temp less than 40 °C. preferably @ 15-30 °C; freezing of the liquid-filled capsules should be avoided.

Solubility

Insoluble

Purity

Purity information is available upon request (COA).

Synonym

clofibrate; 637-07-0; Ethyl 2-(4-chlorophenoxy)-2-methylpropanoate; Ethyl clofibrate; Atromid-S

IUPAC/Chemical Name

ethyl 2-(4-chlorophenoxy)-2-methylpropanoate

InChl Key

KNHUKKLJHYUCFP-UHFFFAOYSA-N

InChl Code

InChI=1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/2796;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download